The Rise of Plai: How an Ancient Thai Root Became a Modern Pharmaceutical Heavyweight
Unlocking the Bio-Chemical Matrix The transition from traditional folk roots to a standardised modern…
Regulatory Scrutiny on Drug Brand Name Extensions: Consumer Protection in Focus, ETPharma
New Delhi: The strategy of using an established brand name to market multiple formulations has come under scrutiny,…
Indian senior citizen’s account comparing US and Indian healthcare goes viral: ‘Medicines for my wife worth Rs 2,500 in India cost Rs 42,000 in US’
Indian senior citizen’s account comparing US and Indian healthcare goes viral: ‘Medicines for my wife worth Rs 2,500…
Worried about ‘Ozempic butt?’ New drug could stop muscle loss tied to weight loss injections
article FILE: GLP-1 weight loss medications (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) A new drug…
NHS atorvastatin warning with serious side effects and drug interactions
Atorvastatin is a type of statin used to lower cholesterol levels in the blood Fiona Callingham Lifestyle writer…
FDA ANNOUNCES RECALL OF HEART, KIDNEY MEDICATIONS
The U.S. Food and Drug Administration has announced the recall of nearly one million bottles of two…
Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available
Share on PinterestFederal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions…
New research aims to get closer to settling the fierce debate over whether GLP-1s are worth the cost – NBC News
New research aims to get closer to settling the fierce debate over whether GLP-1s are worth the cost NBC…
Secret shopper study reveals questionable telehealth GLP-1 practices
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Ramipril and bisoprolol users issued caution by UK government for this week
This is ‘essential advice’ for millions of people. The UK Government has important guidance for millions of people…
How US-UK drug deal will benefit patients | Health
The suggestion that the US-UK pharmaceutical agreement will result in excess deaths is alarmist and relies on a…
‘Nobody should be left alone with a strong drug and a printout’: After Ketto, Kunal Kapoor’s next healthcare bet
India is seeing a growing number of metabolic disorders, prompting a shift in healthcare towards preventative measures before…